Capturing peripheral arterial clot with the Pounce™ Thrombectomy System
Speed When It Matters. Versatility Where It Counts.
Efficient mechanical removal of acute or chronic peripheral arterial thrombi or emboli across a broad 2-10 mm combined vessel diameter range-designed for speed, simplicity, and versatility.
Speed
- NO thrombolytics required for operation of the device
- NO aspiration used for clot removal
- NO capital equipment
- Median of 2 device passes per patient in PROWL registry1
Versatility
- 2–10 mm combined vessel diameter range across device sizes
Readily deployable, streamlined design
Proprietary
dual-basket design
Basket offset and dense mesh pattern for clot capture.
7 Fr Sheath
2–10 mm combined vessel diameter range across device sizes.
- Proprietary dual-basket design Basket offset and dense mesh pattern for clot capture
- 2–10 mm combined vessel diameter range across device sizes.
- 7 Fr Sheath
The basket wire is delivered distal to the location of the thrombus, deploying two nitinol self-expanding baskets.
Length
Compatibility
Compatibility
Diameter
Diameter
Ready to bring the Pounce™ Thrombectomy System to your practice?
Clinical Evidence That Matters
The PROWL registry is a single-arm, retrospective, multicenter, U.S. study of the Pounce™ Thrombectomy System for the non-surgical removal of emboli and thrombi in the peripheral arterial vasculature. (ClinicalTrials.gov Identifier: NCT05868161)
Findings
Results from a subset of 160 acute and chronic patients with symptomatic infrainguinal vessel limb ischemia treated with the Pounce™ Thrombectomy System1
Speed
2.0
Median Device Passes per Patient
24.1min
Average Pounce™ System use time
Effectiveness
78.8%
No additional clot removal treatment of the target lesion after use
Success
91.7%
Procedural success†
Safety
No device-related distal embolization‡
One (0.6%) device-related adverse event(flow-limiting dissection)
Grab, Go, Restore Flow
SFA angiography before (A) and after (B) 2 passes of the Pounce™ System, with thromboembolic debris removed after initial pass (C).2
Clot removed with the
Pounce™ Thrombectomy
System.2
Proprietary dual-basket design
More Real-World Patient Case Examples
Contact Your Local Representative
- Lyden S. Real-world Clinical Outcomes and Case Insights of the Novel Pounce™ Thrombectomy Platform. 23rd Annual Vascular InterVentional Advances (VIVA); November 3rd, 2025; Las Vegas, Nevada.
- Bacharach MJ, Bacharach T. Successful Removal of 20 cm SFA Thrombus With the Pounce™ Thrombectomy System. Endovasc Today. 2022;21(12 Suppl):S12-13.
- The only exclusion criterion in the registry is patient age <18 years.
- Restoration of pulsatile flow in the target lesion(s) with or without adjunctive treatment.
- Distal embolization requiring surgical procedure or obstructing one of the major downstream vessels >70% (at the end of the procedure).
INTENDED USE:
The Pounce™ Thrombectomy System is intended for the non-surgical removal of thrombi and emboli from the peripheral arterial vasculature.
CONTRAINDICATIONS:
- The device is contraindicated for use in patients who cannot receive recommended intravenous anticoagulant therapy.
- The device is not for coronary or neurovascular use.
- The device is not intended to be deployed in vessels with previously implanted devices.
Refer to Instructions for Use for more information concerning Indications, Contraindications, Specific Anatomic Considerations, Warnings, Precautions, and Adverse Events.
CAUTION: Federal (USA) law restricts this device to sale by or on the order of a physician.
NOTE: Not all product components are available in every country.
Please consult with your Endologix representative to confirm product availability.
Endologix, Pounce and the Endologix and Pounce logos are trademarks of Endologix LLC and/or its affiliates. All other trademarks are the respective property of their owners.
© 2026 Endologix, LLC. All rights reserved. MM3052-US Rev 01